SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Friedrich Nietzsche Synthetic CCD

PatientFriedrich Nietzsche
Date of birth1989-10-15
IdentifiersMRN HR-NI019-SYN; SSN (made up) 000-19-5523
Document date2026-11-01
AuthorKonrad Ellison-Mbatha, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Establishing primary care for frequent disabling headaches with nausea and light sensitivity: headache history and red-flag screen, a headache diary, disability and mood screening, the daily combination tablets, MRI and syphilis serology, his eyes and his sleep. Concerns: Headaches on most days that stop him reading and writing, despite moving between climates to escape them; He fears that a brain illness like the one that killed his father may lie behind the headaches; Very poor sight in the right eye and tired eyes when reading; Short, broken sleep. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Butalbital 50 mg, acetaminophen 325 mg and caffeine 40 mg oral tablet, one or two tablets as needed for headache, taken on about 16 days a month, up to four tablets a day (prescribed abroad)One or two tablets as needed, about 16 days a month, up to four a dayOral route2025-11-03 to 2026-07-21stoppedS
Ibuprofen 200 mg oral tablet, two tablets as needed for headache on days without the combination tablets, about 4 days a month (over the counter)Two tablets as needed, about 4 days a monthOral route2025-11-03 to 2026-07-21stoppedS
Butalbital 50 mg, acetaminophen 325 mg and caffeine 40 mg oral tablet, scheduled taper: one tablet twice a day for 7 days, then one tablet a day for 7 days, then one tablet every other day for 7 days, then stopScheduled taper over three weeks: twice a day, then once a day, then every other day, then stop; not for extra dosesOral route2026-07-21 to 2026-08-10completedS
Naproxen 500 mg oral tablet, one tablet with food at the start of a migraine attack, may repeat once after 12 hours; no more than two days a weekOne tablet at attack onset, may repeat once after 12 hours; no more than two days a weekOral route2026-07-21activeS
Metoclopramide 10 mg oral tablet, one tablet with the acute medicine when a migraine attack brings nausea or vomiting; no more than two days a weekOne tablet with the acute medicine when nausea is present, no more than once a dayOral route2026-07-21activeS
Galcanezumab 120 mg/mL auto-injector, 240 mg (two injections) under the skin as a first loading dose, then 120 mg once a month, for chronic migraine preventionLoading dose of 240 mg (two injections) on the first day, then 120 mg every four weeksSubcutaneous route2026-07-21activeS
Sumatriptan 100 mg oral tablet, one tablet early in a migraine attack, may repeat once after 2 hours; no more than two days a week and no more than eight days a monthOne tablet at attack onset, may repeat once after 2 hours; up to 200 mg a day, no more than eight days a monthOral route2026-08-18activeS

Procedures

ProcedureDatesStatusEvidence
MRI of the brain and orbits without and with gadolinium contrast: normal brain; no mass, meningioma or other structural lesion; no white matter lesions; normal pituitary and optic nerves; both globes elongated, the right more than the left, with a posterior staphyloma of the right globe, consistent with high myopia2026-07-21 to 2026-07-21completedS
Comprehensive eye examination with refraction, pupil testing, applanation tonometry, dilated fundus examination with indirect ophthalmoscopy, and macular OCT2026-07-21 to 2026-07-21completedS
Advance care planning conversation, about 16 minutes2026-09-01 to 2026-09-01completedS
Same-day dilated fundus examination of both eyes with indirect ophthalmoscopy and scleral depression by the eye service: Weiss ring in the right eye, no retinal break, detachment, vitreous hemorrhage or pigment in the vitreous2026-08-04 to 2026-08-04completedS
Repeat dilated fundus examination of the right eye with indirect ophthalmoscopy and scleral depression six weeks after the posterior vitreous detachment: no retinal break or detachment2026-09-15 to 2026-09-15completedS

Immunizations

DateVaccineStatusEvidence
2026-09-01Tdap vaccine; last tetanus booster more than ten years agocompletedS
2026-09-01Hepatitis B vaccine (HepB-CpG), first of two dosescompletedS
2026-09-01Influenza vaccine, inactivated, trivalent, preservative free, for the coming seasoncompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
early childhoodSevere myopia, much worse in the right eye, and a right pupil larger than the left, both noted in early childhoodD (CLM-0003)
from about age nineSevere headaches since his school years, mainly right-sided, with light sensitivity, nausea and vomiting, growing more severe in adult lifeD (CLM-0004)
in his twentiesGonorrhea twice in his twenties, by his own accountD (CLM-0010)
1878Right eye found almost blind, with fluid in the retina, diagnosed as retinitisD (CLM-0003)
1879Left his university post for ill health after repeated sick leavesD (CLM-0005, CLM-0006)

Family History

RelativeConditionAge at deathEvidence
fatherDied at 35 or 36 after about a year of seizures and progressive neurological deficits; an autopsy described softening of the brain; cause not established in the cited sourcesD (CLM-0002)

Health Concerns

ConcernStatusEvidence
Headaches on most days that stop him reading and writing, despite moving between climates to escape themactiveS
He fears that a brain illness like the one that killed his father may lie behind the headachesactiveS
Very poor sight in the right eye and tired eyes when readingactiveS
Short, broken sleepactiveS

Assessment

Most recent measures: Because of your headaches on how many days in the last 3 months did you miss work or school [PhenX] 6 on 2026-09-15; Because of your headaches on how many days in the last 3 months was your productivity at work or school reduced by half or more [PhenX] 10 on 2026-09-15; Because of your headaches on how many days in the last 3 months did you not do household work [PhenX] 3 on 2026-09-15; Because of your headaches on how many days in the last 3 months was your productivity in house-hold work reduced by half or more [PhenX] 5 on 2026-09-15; Because of your headaches on how many days in the last 3 months did you miss family, social, or leisure activities [PhenX] 7 on 2026-09-15; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 on 2026-09-15; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 3 on 2026-09-15; Total score [AUDIT-C] 1 on 2026-07-07; Treponema pallidum Ab [Measurement] in Serum 0.12 on 2026-07-21; Right eye Intraocular pressure 15 on 2026-07-21; Left eye Intraocular pressure 14 on 2026-07-21; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 on 2026-09-01 [S]

Strengths and supports: engagement in care [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Frequent disabling headaches on about 20 days a month, with nausea, vomiting and light sensitivity, mostly right-sided, since childhood and more frequent over the past year, with a combination headache tablet containing butalbital taken on about 16 days a month; under evaluation with a headache diary, MRI, syphilis serology and a headache medicine consultationresolvedconfirmed R51.9S — Synthetic presenting problem anchored to his documented headaches; superseded when the consultation confirmed chronic migraine with medication overuse headache.
Chronic migraine without aura (15 or more headache days a month for more than three months, at least 8 with migraine features); ICHD-3 criteria met in a two-week diary; MRI of the brain normal; synthetic modern diagnosis linked to his documented headaches, which historians interpret differentlyactiveconfirmed G43.709S — Synthetic modern diagnosis made at the consultation; the historical diagnosis is disputed (CLM-0014), so this is not a claim about his real diagnosis.
Medication overuse headache from a butalbital, acetaminophen and caffeine combination on 10 or more days a month for more than three months, with ibuprofen on other days; resolved after a three-week taper and withdrawalresolvedconfirmed G44.40S — Synthetic diagnosis made at the consultation, anchored to his documented use of many medicines and sedatives; not a claim about his real medicines.
High myopia in both eyes, much worse in the right eye, since early childhood, with long-standing poor vision in the right eye and unequal pupils; comprehensive eye examination bookedactiveconfirmed H52.13S — Synthetic modern coding of his documented severe myopia.
Pathologic (degenerative) myopia of the right eye with patchy chorioretinal atrophy of the macula, a posterior staphyloma and a tilted optic disc; no choroidal neovascularization on OCT; best corrected vision 20/100 in the right eyeactiveconfirmed H44.2E1S — Synthetic finding of the comprehensive eye examination, anchored to his documented poor right eye and the retrospective reading of it as myopic degeneration; not a claim about his real eyes.
Chronic insomnia, with difficulty falling asleep and early waking, worse on headache nights; no sleep medicine at intakeactiveconfirmed G47.00S — Synthetic sleep problem anchored to his documented severe insomnia; not a claim about his real sleep.
Acute posterior vitreous detachment of the right eye, with flashes and a floater, without a retinal break, detachment or vitreous hemorrhage on dilated examination, in an eye with pathologic myopiaresolvedconfirmed H43.811S — Synthetic acute eye problem in a highly myopic eye; not a historical claim.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-07-07Because of your headaches on how many days in the last 3 months did you miss work or school [PhenX]14dS
2026-07-07Because of your headaches on how many days in the last 3 months was your productivity at work or school reduced by half or more [PhenX]22dS
2026-07-07Because of your headaches on how many days in the last 3 months did you not do household work [PhenX]8dS
2026-07-07Because of your headaches on how many days in the last 3 months was your productivity in house-hold work reduced by half or more [PhenX]12dS
2026-07-07Because of your headaches on how many days in the last 3 months did you miss family, social, or leisure activities [PhenX]18dS
2026-07-07Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S
2026-07-07Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]6{score}S
2026-07-07Total score [AUDIT-C]1{score}S
2026-07-21Treponema pallidum Ab [Measurement] in Serum0.12{index_val}Below 0.90: nonreactiveNormalS
2026-07-21Right eye Intraocular pressure15mm[Hg]10-21 mmHgNormalS
2026-07-21Left eye Intraocular pressure14mm[Hg]10-21 mmHgNormalS
2026-09-01Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
2026-09-15Because of your headaches on how many days in the last 3 months did you miss work or school [PhenX]6dS
2026-09-15Because of your headaches on how many days in the last 3 months was your productivity at work or school reduced by half or more [PhenX]10dS
2026-09-15Because of your headaches on how many days in the last 3 months did you not do household work [PhenX]3dS
2026-09-15Because of your headaches on how many days in the last 3 months was your productivity in house-hold work reduced by half or more [PhenX]5dS
2026-09-15Because of your headaches on how many days in the last 3 months did you miss family, social, or leisure activities [PhenX]7dS
2026-09-15Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-09-15Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]3{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-07-07Body height174cmS
2026-07-07Body weight66kgS
2026-07-07Body mass index (BMI) [Ratio]21.8kg/m2S
2026-07-07Systolic blood pressure118mm[Hg]S
2026-07-07Diastolic blood pressure76mm[Hg]S
2026-07-07Heart rate68/minS
2026-07-07Respiratory rate14/minS
2026-07-07Body temperature36.6CelS
2026-07-07Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-07-21Body height174cmS
2026-07-21Body weight66.2kgS
2026-07-21Body mass index (BMI) [Ratio]21.9kg/m2S
2026-07-21Systolic blood pressure116mm[Hg]S
2026-07-21Diastolic blood pressure74mm[Hg]S
2026-07-21Heart rate66/minS
2026-07-21Respiratory rate14/minS
2026-07-21Body temperature36.5CelS
2026-07-21Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-08-18Body height174cmS
2026-08-18Body weight66.6kgS
2026-08-18Body mass index (BMI) [Ratio]22kg/m2S
2026-08-18Systolic blood pressure114mm[Hg]S
2026-08-18Diastolic blood pressure72mm[Hg]S
2026-08-18Heart rate64/minS
2026-08-18Respiratory rate14/minS
2026-08-18Body temperature36.6CelS
2026-08-18Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-09-15Body height174cmS
2026-09-15Body weight67kgS
2026-09-15Body mass index (BMI) [Ratio]22.1kg/m2S
2026-09-15Systolic blood pressure112mm[Hg]S
2026-09-15Diastolic blood pressure72mm[Hg]S
2026-09-15Heart rate62/minS
2026-09-15Respiratory rate14/minS
2026-09-15Body temperature36.6CelS
2026-09-15Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-09-01Body height174cmS
2026-09-01Body weight66.8kgS
2026-09-01Body mass index (BMI) [Ratio]22.1kg/m2S
2026-09-01Systolic blood pressure112mm[Hg]S
2026-09-01Diastolic blood pressure70mm[Hg]S
2026-09-01Heart rate62/minS
2026-09-01Respiratory rate14/minS
2026-09-01Body temperature36.5CelS
2026-09-01Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-08-04Body height174cmS
2026-08-04Body weight66.4kgS
2026-08-04Body mass index (BMI) [Ratio]21.9kg/m2S
2026-08-04Systolic blood pressure116mm[Hg]S
2026-08-04Diastolic blood pressure74mm[Hg]S
2026-08-04Heart rate66/minS
2026-08-04Respiratory rate14/minS
2026-08-04Body temperature36.6CelS
2026-08-04Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
2026-07-07Establishing primary care for frequent disabling headaches with nausea and light sensitivity: headache history and red-flag screen, a headache diary, disability and mood screening, the daily combination tablets, MRI and syphilis serology, his eyes and his sleepfinishedS
2026-07-21Two-week review of the headache diary, the MRI and the comprehensive eye examination, seen the same day by headache medicine: diagnosis, withdrawal of the overused tablets and preventive treatmentfinishedS
2026-08-18Four-week review after starting galcanezumab and the taper: withdrawal, headache days, acute medicine and the second injectionfinishedS
2026-09-15Eight-week review of prevention: headache days, disability, mood, sleep and the plan aheadfinishedS
2026-09-01Periodic adult preventive visitfinishedS
2026-08-04Same-day sick visit for flashes and floaters in the right eyefinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Diagnosis: a structured headache history, a red-flag screen (SNNOOP10) at every visit, a 14-day diary of headache days, attack features, triggers and every dose of acute medicine, and ICHD-3 criteria; MRI of the brain with and without contrast because the headaches have become more frequent over the past year, are strongly right-sided, and come with long-standing unequal pupils and a very poor right eye; treponemal and nontreponemal syphilis serology because of past gonorrhea, unequal pupils and poor visioncompletedGL-ICHD3-2018, GL-AHS-2021, GL-AHS-CW-2013, GL-CDC-STI-2021S
Neurology (headache medicine) consultation to confirm the diagnosis and advise on withdrawal of the overused tablets and on preventive treatmentcompletedGL-AHS-2021, GL-EAN-MOH-2020, GL-AHS-CGRP-2024S
Medication overuse at intake: explain how frequent combination tablets can keep headaches going; count every tablet and acute-medicine day in the diary; take no more than now and never more than four combination tablets a day until the consultation; no new sedatives or sleeping tabletscompletedGL-EAN-MOH-2020, GL-ICHD3-2018S
Comprehensive eye examination for high myopia: refraction, pupils, pressure, a dilated fundus examination for myopic degeneration, retinal breaks and lattice, and macular OCT; correction of the large difference between the eyes; the warning signs of retinal detachment and an Amsler grid; dilated examination every yearcompletedGL-AAO-RE-2023, GL-AAO-PVD-2025, GL-AAO-CAEE-2026S
Withdrawal: stop ibuprofen and replace as-needed butalbital combination tablets with a scheduled three-week taper (twice a day, then once a day, then every other day), because barbiturates are tapered rather than stopped abruptly; warn about rebound headache in the first one to two weeks and about the rare risk of withdrawal seizures; start prevention at the same timecompletedGL-EAN-MOH-2020, GL-EHF-CGRP-2022, GL-AHS-2021S
Acute treatment after withdrawal: naproxen with metoclopramide early in an attack, no more than two days a week; sumatriptan added once the taper is complete, with no more than eight triptan days a month; no butalbital, opioids or combination products with caffeinecompletedGL-AHS-2021, GL-EAN-MOH-2020, GL-AHS-CW-2013S
Preventive treatment for chronic migraine: galcanezumab 240 mg loading dose, then 120 mg monthly, judged at three months (at least half as many monthly migraine days); topiramate not chosen because of its effects on word-finding and concentration and its rare acute myopia with angle-closure glaucoma, a poor fit for a writer with high myopia; erenumab not chosen because of his constipation; onabotulinumtoxinA, every 12 weeks, as the next option or an additioncompletedGL-AHS-2021, GL-AHS-CGRP-2024, GL-EHF-CGRP-2022, GL-EHF-BOTOX-2018S
Sleep: cognitive behavioral therapy for insomnia through the clinic's behavioral sleep program, a fixed rising time, a wind-down hour, and no sedative sleeping tabletscompletedGL-AASM-INS-2021S
Mood: PHQ-9 and GAD-7 at intake and at about two to three months, with direct questions about hopelessness and self-harm at each visit; a safety assessment if a score or answer calls for onecompletedGL-CMID-2026, GL-USPSTF-DEP-2023S
Reading, writing and walking: good light, large print and an enlarged screen, breaks every 30 minutes, voice dictation for long passages, sunglasses and a brimmed hat for glare, and his daily walks kept as a protected part of the plancompletedGL-AHS-2021, GL-AAO-RE-2023S

Goals

GoalTargetStatusOutcomeProvenance
A two-week headache diary and the tests that allow a firm diagnosis2026-07-21completedDiary of 14 days kept; ICHD-3 criteria for chronic migraine and medication overuse headache met; MRI normal; syphilis serology nonreactiveS
Stop the butalbital combination safely2026-08-18completedThree-week taper completed a week before the four-week review; no withdrawal seizure or delirium; withdrawal headache settled within ten daysS
Fewer than 15 headache days a month, and at least half as many migraine days, within three months of starting prevention2026-10-13activeAt eight weeks: headache days 20 to 7 and migraine days 12 to 4 in the past four weeks; the three-month review is dueS
Acute medicine on no more than eight days a month after withdrawal2026-09-15completedAcute medicine on 5 days in the past four weeks; no butalbital or combination product since the taperS
Clear vision in the left eye for reading and protection of the right eye2026-08-18completedContact lenses fitted; left eye 20/20 and right eye 20/100 corrected; knows the warning signs of retinal detachmentS
Six and a half hours of sleep on most nights without sleeping tablets2026-10-13activeFive and a half to six hours at eight weeks with CBT-I under wayS

Functional Status

Mental Status